Premise: FDA estimates the overall compliance costs of the rule to be from $174 million to $187 million in one-time costs and $149 million to $185 million in annual operating costs.

Hypothesis: The industry has been pushing back against the FDA's compliance requirements for a while now.
Relation: neutral